A pharmaceutical giant has issued a voluntary recall for a high blood pressure medication stating the possible cancer risks. The company in the news release said that they recall Accuretic and two authorized generics distributed by Greenstone due to the presence of Nitrosamines.
Nitrosamines are impurities that could advance cancer risk if people are exposed to them above acceptable levels. People are exposed to some level of Nitrosamines. Nitrosamines are found in water and foods like grilled meats, dairy products, and vegetables.
The pharmaceutical giant says it’s not aware of any adverse reactions but issued the recall out of caution. The company also said that there is no immediate risk to patients taking this medication. People taking the drug must consult their health care provider or pharmacy to determine if they have the affected product. People who own the recalled product are asked to call 888-843-0247 for instructions on returns and reimbursement.
After gaining a breakthrough tag for its maternal vax program earlier this month, the New York pharma has added the same designation to prevent the virus in older adults. PF-06482077, or RSVpreF, snagged the FDA tag Thursday to prevent lower respiratory tract infections from RSV in adults aged 60 and over. The designation comes to phase 2a data Pfizer presented on the shot’s safety, immunogenicity, and efficacy after a single shot in healthy adults aged 18 to 50. The company launched a phase 3 clinical trial called RENOIR for the vaccine in September 2021 to look at the same measures in adults over 60.